{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:14:13Z","timestamp":1728965653536},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T00:00:00Z","timestamp":1355356800000},"content-version":"vor","delay-in-days":134,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Invest"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/bf03261905","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T01:18:28Z","timestamp":1357262308000},"page":"e1-e15","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan\/Quinidine and Memantine in Healthy Volunteers"],"prefix":"10.1007","volume":"32","author":[{"given":"Laura E.","family":"Pope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri A.","family":"Schoedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"issue":"4","key":"BF03261905_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1176\/appi.neuropsych.17.4.447","volume":"17","author":"R. Schiffer","year":"2005","unstructured":"Schiffer R, Pope LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci 2005 Fall; 17 (4): 447\u201354","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"7","key":"BF03261905_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2165\/00023210-200822070-00001","volume":"22","author":"H.S. Wortzel","year":"2008","unstructured":"Wortzel HS, Oster TJ, Anderson CA, et al. Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 2008; 22 (7): 531\u201345","journal-title":"CNS Drugs"},{"issue":"4","key":"BF03261905_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3109\/00048679609065020","volume":"30","author":"F.L. Dark","year":"1996","unstructured":"Dark FL, McGrath JJ, Ron MA. Pathological laughing and crying. Aust N Z J Psychiatry 1996 Aug; 30 (4): 472\u20139","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"BF03261905_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/archneurpsyc.1939.02270220011001","volume":"42","author":"C. Davison","year":"1939","unstructured":"Davison C, Kelman H. Pathologic laughing and crying. Arch Neurol Psychiatry 1939 Oct; 42 (4): 595\u2013643","journal-title":"Arch Neurol Psychiatry"},{"issue":"6","key":"BF03261905_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/jnnp.65.6.928","volume":"65","author":"T. Calvert","year":"1998","unstructured":"Calvert T, Knapp P, House A. Psychological associations with emotionalism after stroke. J Neurol Neurosurg Psychiatry 1998 Dec; 65 (6): 928\u20139","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"BF03261905_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1176\/appi.neuropsych.16.4.426","volume":"16","author":"A. Tateno","year":"2004","unstructured":"Tateno A, Jorge RE, Robinson RG. Pathological laughing and crying following traumatic brain injury. J Neuropsychiatry Clin Neurosci 2004 Fall; 16 (4): 426\u201334","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"BF03261905_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1017\/S1355617708090061","volume":"15","author":"W.K. Tang","year":"2009","unstructured":"Tang WK, Chen Y, Lam WW, et al. Emotional incontinence and executive function in ischemic stroke: a case-controlled study. J Int Neuropsychol Soc 2009 Jan; 15 (1): 62\u20138","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"BF03261905_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/15622970701639445","volume":"10","author":"M.S. Siddiqui","year":"2009","unstructured":"Siddiqui MS, Fernandez HH, Garvan CW, et al. Inappropriate crying and laughing in Parkinson disease and movement disorders. World J Biol Psychiatry 2009; 10 (3): 234\u201340","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"BF03261905_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1176\/appi.neuropsych.21.4.406","volume":"21","author":"G.M. Petracca","year":"2009","unstructured":"Petracca GM, Jorge RE, Aci\u00f3n L, et al. Frequency and correlates of involuntary emotional expression disorder in Parkinson\u2019s disease. J Neuropsych Clin Neurosci 2009 Fall; 21 (4): 406\u201312","journal-title":"J Neuropsych Clin Neurosci"},{"issue":"5","key":"BF03261905_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.20828","volume":"59","author":"H.S. Panitch","year":"2006","unstructured":"Panitch HS, Thisted RA, Smith RA, et al., Pseudobulbar Affect in multiple Sclerosis Study Group. Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 2006 May; 59 (5): 780\u20137","journal-title":"Ann Neurol"},{"issue":"8","key":"BF03261905_CR11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","volume":"63","author":"B.R. Brooks","year":"2004","unstructured":"Brooks BR, Thisted RA, Appel SH, et al., AVP-923 ALS Study Group. Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial. Neurology 2004 Oct; 63 (8): 1364\u201370","journal-title":"Neurology"},{"issue":"5","key":"BF03261905_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ana.22093","volume":"68","author":"E.P. Pioro","year":"2010","unstructured":"Pioro EP, Brooks BR, Cummings J, et al., Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol 2010 Nov; 68 (5): 693\u2013702","journal-title":"Ann Neurol"},{"key":"BF03261905_CR13","unstructured":"Nuedexta [package insert]. Aliso Viejo (CA): Avanir Pharmaceuticals, Inc; 2011"},{"issue":"2","key":"BF03261905_CR14","first-page":"713","volume":"242","author":"D.W. Choi","year":"1987","unstructured":"Choi DW, Peters S, Viseskul V. Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptormediated neurotoxicity on cortical neurons. J Pharmacol Exp Ther 1987 Aug; 242 (2): 713\u201320","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"BF03261905_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","volume":"207","author":"L.L. Werling","year":"2007","unstructured":"Werling LL, Keller A, Frank JG, et al. A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder. Exp Neurol 2007 Oct; 207 (2): 248\u201357","journal-title":"Exp Neurol"},{"issue":"19","key":"BF03261905_CR16","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/0024-3205(89)90510-9","volume":"45","author":"J.M. Musacchio","year":"1989","unstructured":"Musacchio JM, Klein M, Canoll PD. Dextromethorphan and sigma ligands: common sites but diverse effects. Life Sci 1989; 45 (19): 1721\u201332","journal-title":"Life Sci"},{"issue":"10","key":"BF03261905_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1177\/0091270004269521","volume":"44","author":"L.E. Pope","year":"2004","unstructured":"Pope LE, Khalil MH, Berg JE, et al. Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers. J Clin Pharmacol 2004 Oct; 44 (10): 1132\u201342","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"BF03261905_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00002826-198908000-00010","volume":"12","author":"F.O. Walker","year":"1989","unstructured":"Walker FO, Hunt VP. An open label trial of dextromethorphan in Huntington\u2019s disease. Clin Neuropharmacol 1989 Aug; 12 (4): 322\u201330","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"BF03261905_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/clpt.1992.77","volume":"51","author":"Y. Zhang","year":"1992","unstructured":"Zhang Y, Britto MR, Valderhaug KL, et al. Dextromethorphan: enhancing its systemic availability by way of low-dose quinidine-mediated inhibition of cytochrome P4502D6. Clin Pharmacol Ther 1992 June; 51 (6): 647\u201355","journal-title":"Clin Pharmacol Ther"},{"key":"BF03261905_CR20","unstructured":"European Medicines Agency. Ebixa\u00ae (memantine) 10mg film-coated tablets: summary of product characteristics [online]. Available from URL: http:\/\/www.ema.europa.eu [Accessed 2011 Oct 4]"},{"issue":"1","key":"BF03261905_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/jnnp.59.1.55","volume":"59","author":"S.E. Starkstein","year":"1995","unstructured":"Starkstein SE, Migliorelli R, Teson A, et al. Prevalence and clinical correlates of pathological affective display in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry Jul 1995; 59 (1): 55\u201360","journal-title":"J Neurol Neurosurg Psychiatry Jul"},{"issue":"1","key":"BF03261905_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJM199801013380107","volume":"338","author":"A.A. Grace","year":"1998","unstructured":"Grace AA, Camm AJ. Quinidine. N Engl J Med 1998 Jan; 338 (1): 35\u201345","journal-title":"N Engl J Med"},{"issue":"3","key":"BF03261905_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1365-2125.1991.tb05531.x","volume":"31","author":"K. Fattinger","year":"1991","unstructured":"Fattinger K, Vozeh S, Ha HR, et al. Population pharmacokinetics of quinidine. Br J Clin Pharmacol 1991 Mar; 31 (3): 279\u201386","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"BF03261905_CR24","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.clinthera.2005.10.006","volume":"27","author":"N. Rao","year":"2005","unstructured":"Rao N, Chou T, Ventura D, et al. Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide\/metformin in healthy young subjects: a single-center, multiple-dose, open-label study. Clin Ther 2005 Oct; 27 (10): 1596\u2013606","journal-title":"Clin Ther"},{"key":"BF03261905_CR25","unstructured":"Ebixa\u00ae (memantine). Product monograph. Lundbeck. 2002 [online]. Available from URL: http:\/\/www.ebixa.com [Accessed 2011 Oct 4]"},{"issue":"5","key":"BF03261905_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00008571-199610000-00005","volume":"6","author":"T. St\u00fcven","year":"1996","unstructured":"St\u00fcven T, Griese EU, Kroemer HK, et al. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction. Pharmacogenetics 1996 Oct; 6 (5): 417\u201321","journal-title":"Pharmacogenetics"},{"issue":"2","key":"BF03261905_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1046\/j.1365-2125.1999.00993.x","volume":"48","author":"I. Hindmarch","year":"1999","unstructured":"Hindmarch I, Shamsi Z, Stanley N, et al. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol 1999 Aug; 48 (2): 200\u20136","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"BF03261905_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.yebeh.2010.04.022","volume":"18","author":"D. Milovan","year":"2010","unstructured":"Milovan D, Almeida L, Romach MK, et al. Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. Epilepsy Behav 2010 Aug; 18 (4): 366\u201373","journal-title":"Epilepsy Behav"},{"issue":"2","key":"BF03261905_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/BF00229788","volume":"95","author":"J.J. Collins","year":"1993","unstructured":"Collins JJ, De Luca CJ. Open-loop and closed-loop control of posture: a random-walk analysis of center-of-pressure trajectories. Exp Brain Res 1993; 95 (2): 308\u201318","journal-title":"Exp Brain Res"},{"issue":"3","key":"BF03261905_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","volume":"67","author":"A.T. Beck","year":"1996","unstructured":"Beck AT, Steer AT, Ball R, et al. Comparison of Beck Depression Inventories -1A and -II in psychiatric outpatients. J Pers Assess 1996 Dec; 67 (3): 588\u201397","journal-title":"J Pers Assess"},{"issue":"6","key":"BF03261905_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"A.T. Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988 Dec; 56 (6): 893\u20137","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"BF03261905_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00434408","volume":"71","author":"A.S. Parrott","year":"1980","unstructured":"Parrott AS, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations: a review. Psychopharmacology (Berl) 1980; 71 (2): 173\u20139","journal-title":"Psychopharmacology (Berl)"},{"key":"BF03261905_CR33","unstructured":"European Medicines Agency. Guideline on the investigation of bioequivalence. 2008 [online]. Available from URL: http:\/\/www.ema.europa.eu [Accessed 2011 Jun 10]"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03261905\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03261905.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:13:23Z","timestamp":1728922403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF03261905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BF03261905"],"URL":"https:\/\/doi.org\/10.1007\/bf03261905","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"13 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}